Ali Bulent Antmen, MD, PhD

Acibadem Adana Hospital, Turkey

Disclosure(s): Novo Nordisk, Pfizer, Roche, Takeda: Advisor/Consultant

Poster(s):

• 623 - Preliminary Dosing for Adolescent Hematopoietic Stem-Cell Transplant (HSCT) Recipients Based on Pharmacokinetic (PK), Safety, and Efficacy Data of Letermovir (LET) for Cytomegalovirus (CMV) Prophylaxis
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET